Filter News
Area of Research
- (-) Materials (7)
- Biological Systems (1)
- Biology and Environment (16)
- Computational Biology (2)
- Computational Engineering (1)
- Energy Science (6)
- Fusion and Fission (1)
- Isotopes (6)
- Materials for Computing (2)
- National Security (2)
- Neutron Science (14)
- Nuclear Science and Technology (2)
- Supercomputing (17)
News Type
News Topics
- (-) Biomedical (7)
- 3-D Printing/Advanced Manufacturing (23)
- Advanced Reactors (4)
- Artificial Intelligence (9)
- Big Data (2)
- Bioenergy (11)
- Biology (4)
- Buildings (5)
- Chemical Sciences (32)
- Clean Water (3)
- Composites (9)
- Computer Science (17)
- Coronavirus (4)
- Critical Materials (13)
- Cybersecurity (4)
- Energy Storage (34)
- Environment (15)
- Exascale Computing (2)
- Frontier (3)
- Fusion (7)
- Grid (5)
- High-Performance Computing (4)
- Irradiation (1)
- Isotopes (13)
- ITER (1)
- Machine Learning (5)
- Materials (73)
- Materials Science (78)
- Mathematics (1)
- Microscopy (27)
- Molten Salt (3)
- Nanotechnology (39)
- National Security (3)
- Neutron Science (33)
- Nuclear Energy (16)
- Partnerships (11)
- Physics (29)
- Polymers (17)
- Quantum Computing (3)
- Quantum Science (11)
- Security (2)
- Simulation (1)
- Space Exploration (2)
- Summit (2)
- Transportation (14)
ORNL's Communications team works with news media seeking information about the laboratory. Media may use the resources listed below or send questions to news@ornl.gov.
1 - 7 of 7 Results

Scientist-inventors from ORNL will present seven new technologies during the Technology Innovation Showcase on Friday, July 14, from 8 a.m.–4 p.m. at the Joint Institute for Computational Sciences on ORNL’s campus.

Researchers at ORNL explored radium’s chemistry to advance cancer treatments using ionizing radiation.

ORNL scientists will present new technologies available for licensing during the annual Technology Innovation Showcase. The event is 9 a.m. to 3 p.m. Thursday, June 16, at the Manufacturing Demonstration Facility at ORNL’s Hardin Valley campus.

In the race to identify solutions to the COVID-19 pandemic, researchers at the Department of Energy’s 91°µÍř are joining the fight by applying expertise in computational science, advanced manufacturing, data science and neutron science.

The Department of Energy’s 91°µÍř is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.

“Made in the USA.” That can now be said of the radioactive isotope molybdenum-99 (Mo-99), last made in the United States in the late 1980s. Its short-lived decay product, technetium-99m (Tc-99m), is the most widely used radioisotope in medical diagnostic imaging. Tc-99m is best known ...

A novel method developed at 91°µÍř creates supertough renewable plastic with improved manufacturability. Working with polylactic acid, a biobased plastic often used in packaging, textiles, biomedical implants and 3D printing, the research team added tiny amo...